홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

구연산,리튬염

Lithium Citrate

HCID 13520
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
10377-38-5
표준 SMILES
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+]
InChIKey
WJSIUCDMWSDDCE-UHFFFAOYSA-K
분자식
C6H5Li3O7
평균 분자량
210 g/mol
단동위원소 질량
210.0515378

개요

Lithium Citrate can cause developmental toxicity according to state or federal government labeling requirements.

이름 및 식별자

우선 이름
Lithium Citrate
IUPAC
trilithium;2-hydroxypropane-1,2,3-tricarboxylate
현지명
구연산,리튬염
영어명
citric acid, lithium salt
분자식
C6H5Li3O7
분자량
209.9227

이름 및 동의어

Lithium citrateLitarexCITRIC ACID, TRILITHIUM SALTLithium Citrate (anhydrous)anhydrous lithium citrateCHEBI:64735Lithium (as citrate)CHEBI:64754NSC-758700Li-liquidRefChem:55514trilithium(1+) 2-hydroxypropane-1,2,3-tricarboxylate
이름 더 보기
구연산,리튬염Einecs 233-819-9citric acid, lithium salt2-Hydroxy-1,2,3-propanetricarboxylic acid/lithium,(1:x) salt
5Z6E9K79YVLithonate S919-16-4Trilithium citrateCitric acid trilithium saltLithium citrate anhydrousLithium (Citrate)1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trilithium salt

데이터베이스 식별자

CAS
10377-38-5、313222-91-2、6080-58-6、919-16-4
PubChem CID
13520
DTXSID
DTXSID70883185
ChEMBL
CHEMBL1201170、CHEMBL2103738
ChEBI
CHEBI:64735
UNII
3655633623
EC Number
213-045-8、233-819-9、612-032-8、684-184-3

물성

구조 계산 물성

극성 표면적
141 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
7
회전 가능 결합 수
2
무거운 원자 수
16
형식 전하
0
복잡도
211

실험 및 물리화학적 성질

Chemical ClassesMetals -> Organic Acids, Metal Salts
Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physical DescriptionTetrahydrate: White deliquescent solid; [Merck Index]

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 6건

Warning

H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

P264+P265, P280, P305+P351+P338, and P337+P317 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.

This chemical does not meet GHS hazard criteria for 96.4% (27 of 28) of all reports.

Not Classified

유해성 정보

Regulatory Information · 4건

Chemical: 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trilithium salt

Hazard Traits - Developmental Toxicity

REACH registered substance: Lithium citrate (EC: 612-032-8)

Lithium citrate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trilithium salt: Human health tier I assessment
Hazards SummaryMay cause eye irritation; [GFS Chemicals MSDS] See Lithium.
Hazard Classes and Categories · 2건

Not Classified

Eye Irrit. 2 (100%)

안전 및 보호

Exposure Control and Personal Protection0.2 [mg/m3], inhalable fraction, as Li[German Research Foundation (DFG)]

독성 정보

화학 및 산업

약리 정보

Pharmacodynamics · 1건

Although lithium has been used for over 50 years in treatment of bipolar disorder, the mechanism of action is still unknown. Lithium's therapeutic action may be due to a number of effects, ranging from inhibition of enzymes such as glycogen synthase kinase 3, inositol phosphatases, or modulation of glutamate receptors.

Mechanism of Action · 1건

The precise mechanism of action of Li+ as a mood-stabilizing agent is currently unknown. It is possible that Li+ produces its effects by interacting with the transport of monovalent or divalent cations in neurons. An increasing number of scientists have come to the conclusion that the excitatory neurotransmitter glutamate is the key factor in understanding how lithium works. Lithium has been shown to change the inward and outward currents of glutamate receptors (especially GluR3), without a shift in reversal potential. Lithium has been found to exert a dual effect on glutamate receptors, acting to keep the amount of glutamate active between cells at a stable, healthy level, neither too much nor too little. It is postulated that too much glutamate in the space between neurons causes mania, and too little, depression. Another mechanism by which lithium might help to regulate mood include the non-competitive inhibition of an enzyme called inositol monophosphatase. Alternately lithium's action may be enhanced through the deactivation of the GSK-3B enzyme. The regulation of GSK-3B by lithium may affect the circadian clock. GSK-3 is known for phosphorylating and thus inactivating glycogen synthase. GSK-3B has also been implicated in the control of cellular response to damaged DNA. GSK-3 normally phosphorylates beta catenin, which leads to beta catenin degratation. When GSK-3 is inhibited, beta catenin increases and transgenic mice with overexpression of beta catenin express similar behaviour to mice treated with lithium. These results suggest that increase of beta catenin may be a possible pathway for the therapeutic action of lithium.

FDA Pharmacological Classification · 2건

LITHIUM CITRATE

Mood Stabilizer [EPC]

용도 및 제조

관련 반응

8건
반응 기록 만들기
HRID 65823 반응식
HRID 65823반응물로
HRID 723276 반응식
HRID 723276반응물로
HRID 973242 반응식
HRID 973242반응물로
HRID 1029329 반응식
HRID 1029329생성물로
HRID 1155230 반응식
HRID 1155230반응물로
HRID 1448432 반응식
HRID 1448432반응물로
HRID 1716158 반응식
HRID 1716158반응물로
HRID 2250300 반응식
HRID 2250300반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
Nikkaji
J48.475J
Adverse Effects
Neurotoxin - Other CNS neurotoxin

안전 데이터

HS 번호
2918150000
기존화학 물질
KE-06040
Uses
Used as an antidepressant; [Merck Index]
General Manufacturing Information1,2,3-Propanetricarboxylic acid, 2-hydroxy-, lithium salt (1:3): ACTIVE